Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

2 terminated/withdrawn out of 6 trials

Success Rate

60.0%

-26.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05835492Active Not Recruiting

A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD

Role: lead

NCT04744272Not ApplicableWithdrawn

Exploring the Efficacy of myAsthma in Secondary Care

Role: lead

NCT03620630Not ApplicableCompleted

Clinical Efficacy and Cost Effectiveness of MYCOPD in Patients With Mild and Moderate Newly Diagnosed COPD

Role: lead

NCT03511482Not ApplicableWithdrawn

Integrated Digitally Enhanced Care for Long-term Conditions- Asthma

Role: lead

NCT02706613Not ApplicableCompleted

Comparing Online Pulmonary Rehabilitation 'myPR' Versus Conventional Pulmonary Rehabilitation for Patients With COPD

Role: lead

NCT02706600Not ApplicableCompleted

Trial of E-Health Platform Supported Care vs Usual Care After Exacerbation of COPD

Role: lead

All 6 trials loaded